Why Did We Create Lotus?

Boston Mountain Biotech focuses on purification processes in the pharmaceutical industry. Researchers at BMB have developed the patented Lotus® platform that allows biotech manufacturers to produce less contaminant from the very beginning. A purer starting point increases manufacturing efficiency, thus reducing the cost of production.

Lotus simplifies new pharmaceutical product development processes. BMB scientists optimize existing cell lines, so manufacturers can reduce production time, minimize waste, increase product yield – and do all this with minimal disruption to existing manufacturing processes. There’s also minimal FDA impact since Lotus technology optimizes cells already in use.

The result: you can bring valuable new products to market faster and more cost-effectively

Over half of new protein therapeutics never make it to market because they cost too much to develop and take too long to reach clinical trials. In 2012, Forbes magazine reporter Matthew Herper wrote that a typical protein therapeutic development cycle could take up to twelve years in clinical trials and development, and cost $3 to $11 billion. With Lotus, pharmaceutical companies could reduce the development time by half, and their development costs up to $1 to $3 billion.

Lotus technology comes from over twelve years of research in protein manufacturing and purification, with six years of product development, and is supported with funds of over $1 million from the National Science Foundation (NSF) and the Arkansas Biosciences Institute.

How Can Lotus Help You?